Möhnle P, Humpe A, Wittmann G
Abteilung für Transfusionsmedizin, Zelltherapeutika und Hämostaseologie, Klinik für Anaesthesiologie, Universität München (LMU), Marchioninistr. 15, 81377, München, Deutschland.
Anaesthesist. 2018 Sep;67(9):637-646. doi: 10.1007/s00101-018-0483-9.
Correct blood group typing is a prerequisite for transfusion. In most cases blood group determination is without problems; however, in individual cases various factors can complicate blood group determination and sometimes lead to confusing findings. For a better understanding the clinician should have basic knowledge of blood typing. Blood group determination usually covers the AB0 blood groups, Rhesus and Kell systems; in addition, a direct Coombs test and an antibody screening test for the detection of irregular antibodies in the recipient are performed. Confusion of patients, blood samples, results or preparations can lead to severe consequences due to incompatible transfusion and must be prevented. In this context, bedside blood type testing before transfusion is of utmost importance. Problems in laboratory analysis as well as patient-related factors, such as the existence of irregular antibodies against red blood cells can complicate the immunohematology diagnostics. Certain medications, such as daratumumab, lead to a significantly increased complexity in laboratory analyses. Massive transfusions can lead to chimerism with more than one population of circulating red blood cells. Hematopoetic stem cell transplantation can also lead to a change in blood groups as well as chimerism. In addition, there are various other rare causes that can result in difficulties in blood group determination, such as rare blood groups or rare disease-associated phenomena. In the case of problems in blood group determination, early and close cooperation with transfusion medicine is essential for the clinician.
正确的血型鉴定是输血的前提条件。在大多数情况下,血型鉴定并无问题;然而,在个别情况下,多种因素会使血型鉴定变得复杂,有时还会导致令人困惑的结果。为了更好地理解,临床医生应具备血型鉴定的基础知识。血型鉴定通常涵盖AB0血型、恒河猴血型和凯尔血型系统;此外,还会进行直接抗人球蛋白试验和抗体筛查试验,以检测受血者体内的不规则抗体。由于输血不相容,患者、血样、结果或制剂的混淆可能导致严重后果,必须加以预防。在此背景下,输血前的床边血型检测至关重要。实验室分析中的问题以及与患者相关的因素,如存在针对红细胞的不规则抗体,会使免疫血液学诊断变得复杂。某些药物,如达雷妥尤单抗,会导致实验室分析的复杂性显著增加。大量输血可导致出现具有不止一种循环红细胞群体的嵌合体。造血干细胞移植也可导致血型改变以及嵌合体的出现。此外,还有各种其他罕见原因可导致血型鉴定困难,如罕见血型或与罕见疾病相关的现象。在血型鉴定出现问题的情况下,临床医生与输血医学尽早并密切合作至关重要。